Outline of this study (IMAGE)
Caption
The research team identified a GLS1 inhibitor that selectively removes senescent cells, found that administration of the GLS1 inhibitor improves age-related tissue dysfunction and the symptoms of obese diabetes, arteriosclerosis, and NASH.
Credit
©NAKANISHI Makoto, The Institute of Medical Science, The University of Tokyo(IMSUT)
Usage Restrictions
The image may only be used with appropriate caption or credit.
License
Licensed content